Slashdot Mirror


Biotech Report Says IP Spurs Innovation

ananyo writes "A report presented at the 2012 BIO International Convention in Boston, Massachusetts suggests that patents do not stifle progress when they occur at early phases of research, as some have suggested. Over the past decade, increases in patents have been matched by growth in the biotech and pharmaceutical sectors in India, Brazil, Singapore and other countries with emerging economies. The strength of patent rights can be quantified in an index ranging from 0 (no patent rights) to 5 (very strong). Over time, the countries that U.S. biotech and pharmaceutical companies have invested in have moved up the IP barometer, the report (PDF) says."

4 of 126 comments (clear)

  1. Lets Stick to Software Patents by utkonos · · Score: 5, Insightful

    Let's all focus on software patents rather than all patents in general. The argument is much more cut and dry. If we focus all our energy on getting rid of software patents, I think it would be more beneficial than trying to reform all patent law. Once we've gotten rid of software patents, then we can move to reforming the patent law in regards to areas that are much more gray.

    1. Re:Lets Stick to Software Patents by KiloByte · · Score: 5, Insightful

      Singling out software patents would be selfish -- let's fix this for everyone.

      --
      The creatures outside looked from Alt-Right to Antifa; but already it was impossible to say which was which.
  2. in related news by circletimessquare · · Score: 4, Insightful

    people invested in a broken system have enough to lose to profess faith in the broken system

    --
    intellectual property law is philosophically incoherent. it is your moral duty to ignore it or sabotage it
  3. American companies insist on rights by Anonymous Coward · · Score: 4, Insightful

    American companies insist on having rights! The fact that they are getting those rights does not mean the rights are doing anyone any good. In fact the pharmaceutical industry is in trouble because they've been leaning on their patents instead of doing basic research. Now the patents are expiring and the companies have nothing else to offer. In that light, the patent system is doing tremendous harm.